Published in Rheumatology (Oxford) on January 16, 2009
The status of serum vitamin D in patients with rheumatoid arthritis and undifferentiated inflammatory arthritis compared with controls. Rheumatol Int (2011) 0.93
Bone mineral density changes in patients with recent-onset rheumatoid arthritis. Clin Med Insights Arthritis Musculoskelet Disord (2011) 0.82
Inflammation fuels tumor progress and metastasis. Curr Pharm Des (2015) 0.81
Effects of rituximab treatment on the serum concentrations of vitamin D and interleukins 2, 6, 7, and 10 in patients with rheumatoid arthritis. Biologics (2012) 0.79
Vitamin D receptor FokI, BsmI, and TaqI polymorphisms and susceptibility to rheumatoid arthritis : A meta-analysis. Z Rheumatol (2016) 0.78
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature (2007) 144.95
The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum (1987) 14.21
Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. N Engl J Med (1995) 13.01
Prediction of bone density from vitamin D receptor alleles. Nature (1994) 5.36
Vitamin D intake is inversely associated with rheumatoid arthritis: results from the Iowa Women's Health Study. Arthritis Rheum (2004) 4.77
1,25-dihydroxyvitamin D3 receptors in human leukocytes. Science (1983) 4.34
Severe functional declines, work disability, and increased mortality in seventy-five rheumatoid arthritis patients studied over nine years. Arthritis Rheum (1984) 3.33
Specific high-affinity receptors for 1,25-dihydroxyvitamin D3 in human peripheral blood mononuclear cells: presence in monocytes and induction in T lymphocytes following activation. J Clin Endocrinol Metab (1983) 3.27
Genetic determinants of bone mass in adults. A twin study. J Clin Invest (1987) 3.23
Association between serum vitamin D metabolite levels and disease activity in patients with early inflammatory polyarthritis. Arthritis Rheum (2007) 3.14
A vitamin D receptor gene polymorphism in the translation initiation codon: effect on protein activity and relation to bone mineral density in Japanese women. J Bone Miner Res (1997) 2.46
Reduced bone density and osteoporosis associated with a polymorphic Sp1 binding site in the collagen type I alpha 1 gene. Nat Genet (1996) 2.23
Contribution of trans-acting factor alleles to normal physiological variability: vitamin D receptor gene polymorphism and circulating osteocalcin. Proc Natl Acad Sci U S A (1992) 2.20
High-sensitivity C-reactive protein and risk of nontraumatic fractures in the Bruneck study. Arch Intern Med (2006) 2.09
1,25-Dihydroxycholecalciferol inhibits the progression of arthritis in murine models of human arthritis. J Nutr (1998) 2.06
Effect of vitamin D receptor gene alleles on bone loss in early rheumatoid arthritis. J Rheumatol (1998) 2.05
Vitamin D-receptor gene polymorphisms and bone density in prepubertal American girls of Mexican descent. N Engl J Med (1997) 1.96
Genetic influences on muscle strength, lean body mass, and bone mineral density: a twin study. J Bone Miner Res (1997) 1.91
Genetic determinants of bone mass in adult women: a reevaluation of the twin model and the potential importance of gene interaction on heritability estimates. J Bone Miner Res (1991) 1.82
Heritable and life-style determinants of bone mineral density. J Bone Miner Res (1993) 1.78
Large-scale evidence for the effect of the COLIA1 Sp1 polymorphism on osteoporosis outcomes: the GENOMOS study. PLoS Med (2006) 1.68
Immunomodulatory role of 1,25-dihydroxyvitamin D3. J Cell Biochem (1992) 1.61
Calcium and vitamin D: skeletal and extraskeletal health. Curr Rheumatol Rep (2008) 1.54
Association of bone mineral density with polymorphism of the estrogen receptor gene. J Bone Miner Res (1996) 1.45
Meta-analysis of COL1A1 Sp1 polymorphism in relation to bone mineral density and osteoporotic fracture. Bone (2003) 1.44
Meta-analysis of molecular association studies: vitamin D receptor gene polymorphisms and BMD as a case study. J Bone Miner Res (2003) 1.42
The association of bone mineral density with vitamin D receptor gene polymorphisms. Osteoporos Int (1999) 1.38
Interactions of 1,25-dihydroxyvitamin D3 and the immune system. Mol Cell Endocrinol (1985) 1.32
The caudal-related homeodomain protein Cdx-2 regulates vitamin D receptor gene expression in the small intestine. J Bone Miner Res (1999) 1.31
Association of estrogen receptor dinucleotide repeat polymorphism with osteoporosis. Biochem Biophys Res Commun (1995) 1.26
ApaI, BsmI, EcoRV and TaqI polymorphisms at the human vitamin D receptor gene locus in Caucasians, blacks and Asians. Hum Mol Genet (1993) 1.20
Cdx-2 polymorphism in the promoter region of the human vitamin D receptor gene determines susceptibility to fracture in the elderly. J Bone Miner Res (2003) 1.18
Vitamin D receptor allele combinations influence genetic susceptibility to type 1 diabetes in Germans. Diabetes (2000) 1.14
Association of vitamin D receptor gene polymorphism with multiple sclerosis in Japanese. J Neurol Sci (1999) 1.11
The skeleton in rheumatoid arthritis: common mechanisms for bone erosion and osteoporosis? J Rheumatol (2000) 1.07
Bone mineral density and its change in white women: estrogen and vitamin D receptor genotypes and their interaction. J Bone Miner Res (1998) 1.03
Association of collagen Ialpha 1 Sp1 polymorphism with the risk of prevalent fractures: a meta-analysis. J Bone Miner Res (2001) 1.01
Allelic variation in the vitamin D receptor influences susceptibility to IDDM in Indian Asians. Diabetologia (1997) 0.99
Family history of osteoporosis and bone mineral density at the axial skeleton: the Rancho Bernardo Study. J Bone Miner Res (1994) 0.97
Association of the G-174C variant in the interleukin-6 promoter region with bone loss and fracture risk in older women. J Bone Miner Res (2004) 0.96
A functional polymorphic variant in the interleukin-6 gene promoter associated with low bone resorption in postmenopausal women. Arthritis Rheum (2001) 0.96
Evidence for nonrenal synthesis of 1,25-dihydroxyvitamin D in patients with inflammatory arthritis. J Bone Miner Res (1991) 0.95
Interleukin-6 promoter polymorphism is associated with bone quality assessed by calcaneus ultrasound and previous fractures in a cohort of 75-year-old women. Osteoporos Int (2004) 0.94
Estrogen receptor alpha gene polymorphisms and bone mineral density: haplotype analysis in women from the United Kingdom. J Bone Miner Res (2001) 0.94
Vitamin D receptors in the rheumatoid lesion: expression by chondrocytes, macrophages, and synoviocytes. Ann Rheum Dis (1999) 0.94
Linkage disequilibrium between polymorphisms in the human TNFRSF1B gene and their association with bone mass in perimenopausal women. Hum Mol Genet (2002) 0.93
Interaction between the vitamin D receptor gene and collagen type Ialpha1 gene in susceptibility for fracture. J Bone Miner Res (2001) 0.88
Vitamin D receptor gene polymorphism in rheumatoid arthritis and associated osteoporosis. Rheumatol Int (2006) 0.84
Association of vitamin D receptor genotypes with early onset rheumatoid arthritis. Eur J Immunogenet (2001) 0.82
Association of a polymorphism in the TNFR2 gene with low bone mineral density. J Bone Miner Res (2000) 0.81
Association tests of interleukin-6 (IL-6) and type II tumor necrosis factor receptor (TNFR2) genes with bone mineral density in Caucasians using a re-sampling approach. Hum Genet (2005) 0.81
Vitamin D receptor genotypes are not associated with rheumatoid arthritis or biochemical parameters of bone turnover in German RA patients. Clin Exp Rheumatol (2003) 0.80
Lack of relationship between vitamin D receptor polymorphism and bone erosion in rheumatoid arthritis. J Korean Med Sci (2001) 0.80